Aerie Pharmaceuticals announced the appointment of Concetta Perro as Commercial Counsel, reporting to John LaRocca, Aerie’s General Counsel. Perro will direct a broad spectrum of commercial contracting activities. Perro previously held a related position at GE Healthcare Life Sciences, a division of GE Healthcare.
In connection with her acceptance of the position as Commercial Counsel, Perro will receive awards totaling 14,400 stock options that will vest over 4 years, with 25% vesting on the first anniversary of the hire date and the remainder vesting ratably on each of the subsequent 36 monthly anniversaries of the hire date. This award was made outside of Aerie’s stockholder-approved equity incentive plan and was approved by the Company’s independent directors as an inducement material to Ms. Perro entering into employment with the Company in reliance on NASDAQ Listing Rule 5635(c)(4), which requires this public announcement.